drugset / Trial / NCT03537612

Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain

NCT03537612 ↗

Phase 3 Terminated 15 enrolled Dr. Jean A. Ouellet, MD, FRCSC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The overall goal of this proposal is to determine if quantitative sensory testing (QST) assessing pain modulation can be used as a clinical tool to optimize perioperative pain management. The central hypothesis is that the identification of patient's sensory pain profile allows personalizing therapeutic approaches to improve individualized pain management and thus prevents pain chronicity.

Timeline

Start
2018-06-22
Primary completion
2022-04-05
Completion
2022-04-05

Outcome

Outcome not reported

Stopped (Enrollment): “Do to our inability to meet recruitment targets - Sponsor stopped funding. Looking for new sponsor and protocol modifications”

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 100 ug Intrathecal
Subject Morphine Other / unclassified 5 ug/kg Intrathecal

Indications